TARO-AMCINONIDE 0.1 % — DIN 02246714
AMCINONIDE : 0.1 % · TARO PHARMACEUTICALS INC · CREAM · wholesale supply in Canada
Health Canada status: MARKETED
What is TARO-AMCINONIDE?
TARO-AMCINONIDE 0.1 % contains AMCINONIDE : 0.1 %. It is listed in the Health Canada Drug Product Database under DIN 02246714, held by TARO PHARMACEUTICALS INC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as marketed, status dated 24-Oct-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TARO-AMCINONIDE used for?
TARO-AMCINONIDE (amcinonide) is a high potency topical corticosteroid indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses for a maximum duration of 5 days on the face, axillae, scrotum and scalp and a maximum of 3 weeks on the body.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Is there a generic Amcinonide in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
4 holders have a Canadian DIN containing Amcinonide, across 11 DINs, of which 1 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TARO PHARMACEUTICALS INC | 2 | 1 | TARO-AMCINONIDE | Sourceable in Canada |
| GLAXOSMITHKLINE INC | 3 | 0 | CYCLOCORT | No marketed DIN |
| LEDERLE CYANAMID CANADA INC. | 3 | 0 | CYCLOCORT CRM 0.1%, CYCLOCORT LOT 0.1%, CYCLOCORT ONT 0.1% | No marketed DIN |
| TEVA CANADA LIMITED | 3 | 0 | RATIO-AMCINONIDE | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 0.1 % |
|---|---|
| Dosage form | CREAM |
| Route | TOPICAL |
| Pack configuration (monograph) | TARO-AMCINONIDE ointment is available in 15, 30, and 60 grams laminate tubes. TARO-AMCINONIDE cream is available in 15, 30, and 60 grams laminate tubes, and in 100 grams polypropylene jars. |
| Storage | controlled room temperature 15°-30°C. Keep the container tightly closed. Avoid freezing. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Substance and classification
| Active substance | Amcinonide |
|---|---|
| ATC code | D07AC11 |
| AHFS class | 84:06.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02246714 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2246714 |
| Brand name | TARO-AMCINONIDE |
| Generic / active ingredient | AMCINONIDE : 0.1 % |
| Market authorization holder | TARO PHARMACEUTICALS INC |
| Health Canada schedule | Prescription |
| ATC code | D07AC11 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D07AC |
| Current status | MARKETED |
| Status date | 24-Oct-2005 |
| Original market date | 2003-02-13 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
1 of 11 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| CYCLOCORT | 0.1 % | OINTMENT | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | 02192268 |
| CYCLOCORT | 0.1 % | CREAM | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | 02192284 |
| CYCLOCORT | 0.1 % | LOTION | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | 02192276 |
| CYCLOCORT CRM 0.1% | .1 % | CREAM | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | 00443824 |
| CYCLOCORT LOT 0.1% | .1 % | LOTION | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | 00571016 |
| CYCLOCORT ONT 0.1% | .1 % | OINTMENT | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | 00559237 |
| RATIO-AMCINONIDE | 0.1 % | OINTMENT | TEVA CANADA LIMITED | CANCELLED POST MARKET | 02247096 |
| RATIO-AMCINONIDE | 0.1 % | LOTION | TEVA CANADA LIMITED | CANCELLED POST MARKET | 02247097 |
| RATIO-AMCINONIDE | 0.1 % | CREAM | TEVA CANADA LIMITED | CANCELLED POST MARKET | 02247098 |
| TARO-AMCINONIDE | 0.1 % | OINTMENT | TARO PHARMACEUTICALS INC | CANCELLED PRE MARKET | 02257416 |
2 · Same class — other molecules in ATC D07AC
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Betamethasone | BEBEN GEL 0.025% · BETACORT SCALP LOTION 0.1% · BETADERM CRM 0.05% · BETADERM CRM 0.1% · +55 more | 73 | 20 | Yes |
| Mometasone | ELOCOM · PMS-MOMETASONE · TARO-MOMETASONE CREAM · TARO-MOMETASONE LOTION · +2 more | 11 | 6 | Yes |
| Fluocinonide | LIDEMOL · LIDEMOL 0.05% · LIDEX · LIDEX CREAM MILD 0.01% · +10 more | 18 | 4 | Yes |
| Desoximetasone | DESOXI CREAM 0.05% · DESOXI CREAM 0.25% · DESOXI GEL 0.05% · TOPICORT · +6 more | 14 | 4 | Yes |
| Ulobetasol | BRYHALI · ULTRAVATE | 3 | 3 | Yes |
| Fluocinolone Acetonide | CAPEX · DERMA SMOOTHE/FS LIQ 0.01% · FLUODERM CRM 0.01% · FLUODERM CRM 0.025% · +10 more | 15 | 1 | Yes |
| Amcinonide | CYCLOCORT · CYCLOCORT CRM 0.1% · CYCLOCORT LOT 0.1% · CYCLOCORT ONT 0.1% · +2 more | 11 | 1 | Yes |
| Beclometasone | PROPADERM · PROPADERM CREAM 0.025% · PROPADERM LOT 0.025% · PROPADERM LOTION 0.025% | 4 | 1 | Yes |
| Prednicarbate | DERMATOP EMOLLIENT CREAM · DERMATOP OINTMENT | 2 | 1 | Yes |
| Diflucortolone | NERISONE CREAM · NERISONE OILY CREAM · NERISONE OINTMENT | 3 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC D07A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| D07AD | Clobetasol · Halcinonide | 43 | 20 |
| D07AB | Clobetasone · Desonide · Flumetasone · Triamcinolone | 32 | 7 |
| D07AA | Hydrocortisone · Methylprednisolone | 35 | 3 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.